FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2322842969> ?p ?o ?g. }

• W2322842969 endingPage "972" @default.
• W2322842969 startingPage "972.1" @default.
• W2322842969 abstract "<h3>Background</h3> In vitro, the key B-cell cytokine BAFF (B-lymphocyte activating factor) differentially promotes the survival of transitional B-cells and plasmablasts through interaction with specific receptors. Following rituximab (RTX) therapy in patients with systemic lupus erythematosus (SLE), serum BAFF levels increase. The aim was to determine the effect of RTX treatment on relationships amongst BAFF, B cell sub-populations and BAFF receptor (BAFF-R). <h3>Methods</h3> Twenty-three RTX-naïve (RTX-N) and 12 RTX-treated (RTX-T) SLE patients and six healthy controls (HCs) were included. RTX-N and RTX-T patients had comparable organ involvement, background therapy (including corticosteroids) and baseline %CD19+B-cells. The relationships amongst serum BAFF levels (ELISA), %B-cell sub-populations (FACS analysis using monoclonal antibodies to CD19, IgD, CD27, CD38) and %BAFF-R+ cells within each B-cell sub-population were compared between RTX-N, RTX-T and HCs. Data were analysed using Mann Whitney U and Spearman Rank correlation tests. <h3>Results</h3> BAFF levels were significantly higher in RTX-T patients compared with RTX-N patients (p<0.005) despite similar %CD19+B-cells, and both groups had higher levels than HC (p<0.05). RTX-N patients had lower % naïve B-cells (IgD+CD27-) and higher %IgD-CD27- B-cells compared with HCs (p=0.01, 0.002, respectively). Following RTX treatment %CD38++/+++ cells (transitional IgD+CD38++ (p<0.05) and plasmablasts (IgD-CD38+++)) were significantly higher compared with HCs (p<0.05), but with no significant difference between RTX-N and RTX-T patients in the frequency of plasmablasts. Moreover, there was a significant reduction in the frequency of BAFF-R+ plasmablasts after RTX (p<0.05). Positive correlations were found between serum BAFF and %transitional cells (r²=0.69, p<0.0001) and plasmablasts (r2=0.61, p<0.0001) in RTX-N patients, but not in RTX-T patients. In RTX-N patients, BAFF levels and %BAFF-R+B-cells were negatively correlated in total CD19+B-cells (r²=0.49, p=0.0003), in naive B-cells (r²=0.51, p=0.0002); and in post-switched B-cells (IgD-CD27+) (r²=0.5, p=0.0002). No such correlations were found after RTX. In RTX-N patients, there was a positive correlation between BAFF levels with total IgM and anti-dsDNA (r²=0.53, 0.48, respectively; p<0.005 for both) (median 908 IU) but not in RTX-T patients (median anti-dsDNA 558 IU). <h3>Conclusions</h3> These results suggest that (IgD+ and IgD-) CD38++ B-cells were differently sensitive to BAFF-mediated effects in RTX-N patients, compared with RTX-T patients. RTX may therefore disrupt the aberrant interaction between BAFF and B-cells in RTX-N SLE patients. Serum anti-dsDNA antibodies and total IgM also correlated with BAFF levels in RTX-N patients but not in RTX-T. RTX may therefore act by removing autoantibodies/immune complexes, which may be responsible for altering the functional consequences of BAFF in both apparently disparate CD38++ B cell sub-populations. <h3>Disclosure of Interest</h3> None declared <h3>DOI</h3> 10.1136/annrheumdis-2014-eular.4544" @default.
• W2322842969 created "2016-06-24" @default.
• W2322842969 creator A5040857760 @default.
• W2322842969 creator A5065798696 @default.
• W2322842969 creator A5069297340 @default.
• W2322842969 creator A5072708850 @default.
• W2322842969 creator A5091310119 @default.
• W2322842969 date "2014-06-01" @default.
• W2322842969 modified "2023-10-04" @default.
• W2322842969 title "AB0499 Changes in the Relationship between Baff, BAFF-R and B Cell Phenotype following Treatment with Rituximab in Patients with Systemic Lupus Erythematosus" @default.
• W2322842969 doi "https://doi.org/10.1136/annrheumdis-2014-eular.4544" @default.
• W2322842969 hasPublicationYear "2014" @default.
• W2322842969 type Work @default.
• W2322842969 sameAs 2322842969 @default.
• W2322842969 citedByCount "0" @default.
• W2322842969 crossrefType "journal-article" @default.
• W2322842969 hasAuthorship W2322842969A5040857760 @default.
• W2322842969 hasAuthorship W2322842969A5065798696 @default.
• W2322842969 hasAuthorship W2322842969A5069297340 @default.
• W2322842969 hasAuthorship W2322842969A5072708850 @default.
• W2322842969 hasAuthorship W2322842969A5091310119 @default.
• W2322842969 hasConcept C10205521 @default.
• W2322842969 hasConcept C126322002 @default.
• W2322842969 hasConcept C159654299 @default.
• W2322842969 hasConcept C159912055 @default.
• W2322842969 hasConcept C170286685 @default.
• W2322842969 hasConcept C18031839 @default.
• W2322842969 hasConcept C203014093 @default.
• W2322842969 hasConcept C2776912625 @default.
• W2322842969 hasConcept C2778453870 @default.
• W2322842969 hasConcept C2778690821 @default.
• W2322842969 hasConcept C2778957590 @default.
• W2322842969 hasConcept C2779134260 @default.
• W2322842969 hasConcept C2780653079 @default.
• W2322842969 hasConcept C28328180 @default.
• W2322842969 hasConcept C2908647359 @default.
• W2322842969 hasConcept C48010095 @default.
• W2322842969 hasConcept C54355233 @default.
• W2322842969 hasConcept C71924100 @default.
• W2322842969 hasConcept C86803240 @default.
• W2322842969 hasConcept C99454951 @default.
• W2322842969 hasConceptScore W2322842969C10205521 @default.
• W2322842969 hasConceptScore W2322842969C126322002 @default.
• W2322842969 hasConceptScore W2322842969C159654299 @default.
• W2322842969 hasConceptScore W2322842969C159912055 @default.
• W2322842969 hasConceptScore W2322842969C170286685 @default.
• W2322842969 hasConceptScore W2322842969C18031839 @default.
• W2322842969 hasConceptScore W2322842969C203014093 @default.
• W2322842969 hasConceptScore W2322842969C2776912625 @default.
• W2322842969 hasConceptScore W2322842969C2778453870 @default.
• W2322842969 hasConceptScore W2322842969C2778690821 @default.
• W2322842969 hasConceptScore W2322842969C2778957590 @default.
• W2322842969 hasConceptScore W2322842969C2779134260 @default.
• W2322842969 hasConceptScore W2322842969C2780653079 @default.
• W2322842969 hasConceptScore W2322842969C28328180 @default.
• W2322842969 hasConceptScore W2322842969C2908647359 @default.
• W2322842969 hasConceptScore W2322842969C48010095 @default.
• W2322842969 hasConceptScore W2322842969C54355233 @default.
• W2322842969 hasConceptScore W2322842969C71924100 @default.
• W2322842969 hasConceptScore W2322842969C86803240 @default.
• W2322842969 hasConceptScore W2322842969C99454951 @default.
• W2322842969 hasIssue "Suppl 2" @default.
• W2322842969 hasLocation W23228429691 @default.
• W2322842969 hasOpenAccess W2322842969 @default.
• W2322842969 hasPrimaryLocation W23228429691 @default.
• W2322842969 hasRelatedWork W1982430774 @default.
• W2322842969 hasRelatedWork W2051022408 @default.
• W2322842969 hasRelatedWork W2155087150 @default.
• W2322842969 hasRelatedWork W2158050746 @default.
• W2322842969 hasRelatedWork W2322842969 @default.
• W2322842969 hasRelatedWork W2609245539 @default.
• W2322842969 hasRelatedWork W2803903323 @default.
• W2322842969 hasRelatedWork W3008372023 @default.
• W2322842969 hasRelatedWork W4288050659 @default.
• W2322842969 hasRelatedWork W2488804193 @default.
• W2322842969 hasVolume "73" @default.
• W2322842969 isParatext "false" @default.
• W2322842969 isRetracted "false" @default.
• W2322842969 magId "2322842969" @default.
• W2322842969 workType "article" @default.